WO2012123924A3 - Composition antimicrobienne - Google Patents
Composition antimicrobienne Download PDFInfo
- Publication number
- WO2012123924A3 WO2012123924A3 PCT/IB2012/051280 IB2012051280W WO2012123924A3 WO 2012123924 A3 WO2012123924 A3 WO 2012123924A3 IB 2012051280 W IB2012051280 W IB 2012051280W WO 2012123924 A3 WO2012123924 A3 WO 2012123924A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antimicrobial
- antimicrobial composition
- aggregation
- composition including
- silver particles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Dermatology (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne une composition antimicrobienne présentant des propriétés antimicrobiennes et une activité vis-à-vis de, entre autres, la tuberculose (TB), la malaria et le cancer. Plus particulièrement, mais non exclusivement, la présente invention concerne une composition antimicrobienne présentant une activité antimicrobienne, utile dans le traitement et la prévention d'infections, de maladies et/ou de troubles. La présente invention concerne en outre des procédés de préparation de la composition antimicrobienne et l'utilisation de ladite composition dans la fabrication de préparations antimicrobiennes pour le traitement et/ou la prévention d'infections, de maladies et/ou de troubles.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AP2013007143A AP2013007143A0 (en) | 2011-03-16 | 2012-03-16 | Antimicrobial composition |
ZA2013/07018A ZA201307018B (en) | 2011-03-16 | 2013-09-18 | Antimicrobial composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA2011/01612 | 2011-03-16 | ||
ZA201101612 | 2011-03-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012123924A2 WO2012123924A2 (fr) | 2012-09-20 |
WO2012123924A3 true WO2012123924A3 (fr) | 2013-06-06 |
Family
ID=45937484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2012/051280 WO2012123924A2 (fr) | 2011-03-16 | 2012-03-16 | Composition antimicrobienne |
Country Status (3)
Country | Link |
---|---|
AP (1) | AP2013007143A0 (fr) |
WO (1) | WO2012123924A2 (fr) |
ZA (1) | ZA201307018B (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2675692C1 (ru) * | 2017-08-18 | 2018-12-21 | Дамир Зиннатович Хабибуллин | Способ воздействия на микобактерии туберкулеза в эксперименте in vitro |
US11896612B2 (en) | 2019-03-29 | 2024-02-13 | Board Of Trustees Of Michigan State University | Resurrection of antibiotics that MRSA resists by silver-doped bioactive glass-ceramic particles |
CN115414360A (zh) * | 2022-08-30 | 2022-12-02 | 上海交通大学医学院附属仁济医院 | 全反式维甲酸联合抗生素在治疗假体周围感染中的应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060090598A1 (en) * | 2004-11-03 | 2006-05-04 | Goia Dan V | Aqueous-based method for producing ultra-fine silver powders |
US20060264518A1 (en) * | 2003-04-28 | 2006-11-23 | Kenji Kato | Method for preparing liquid colloidal dispersion of silver particles, liquid colloidal dispersion of silver particles, and silver conductive film |
JP2008001961A (ja) * | 2006-06-23 | 2008-01-10 | Fujifilm Corp | 金属微粒子分散物、着色組成物、感光性転写材料、遮光画像付き基板、カラーフィルタ、及び表示装置 |
JP2009019235A (ja) * | 2007-07-11 | 2009-01-29 | Toda Kogyo Corp | 銀ナノ粒子の水性分散液およびその製造方法 |
JP2009030111A (ja) * | 2007-07-27 | 2009-02-12 | Sumitomo Metal Mining Co Ltd | 銀微粒子コロイド分散液および銀膜 |
US20090256118A1 (en) * | 2005-12-08 | 2009-10-15 | Hiroyuki Tanaka | Fine Silver Particle Colloidal Dispersion, Coating Liquid for Silver Film Formation, Processes for Producing These, and Silver Film |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3761590A (en) | 1970-05-18 | 1973-09-25 | Research Corp | Silver sulfadiazine used in the treatment of burns |
-
2012
- 2012-03-16 WO PCT/IB2012/051280 patent/WO2012123924A2/fr active Application Filing
- 2012-03-16 AP AP2013007143A patent/AP2013007143A0/xx unknown
-
2013
- 2013-09-18 ZA ZA2013/07018A patent/ZA201307018B/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060264518A1 (en) * | 2003-04-28 | 2006-11-23 | Kenji Kato | Method for preparing liquid colloidal dispersion of silver particles, liquid colloidal dispersion of silver particles, and silver conductive film |
US20060090598A1 (en) * | 2004-11-03 | 2006-05-04 | Goia Dan V | Aqueous-based method for producing ultra-fine silver powders |
US20090256118A1 (en) * | 2005-12-08 | 2009-10-15 | Hiroyuki Tanaka | Fine Silver Particle Colloidal Dispersion, Coating Liquid for Silver Film Formation, Processes for Producing These, and Silver Film |
JP2008001961A (ja) * | 2006-06-23 | 2008-01-10 | Fujifilm Corp | 金属微粒子分散物、着色組成物、感光性転写材料、遮光画像付き基板、カラーフィルタ、及び表示装置 |
JP2009019235A (ja) * | 2007-07-11 | 2009-01-29 | Toda Kogyo Corp | 銀ナノ粒子の水性分散液およびその製造方法 |
JP2009030111A (ja) * | 2007-07-27 | 2009-02-12 | Sumitomo Metal Mining Co Ltd | 銀微粒子コロイド分散液および銀膜 |
Also Published As
Publication number | Publication date |
---|---|
ZA201307018B (en) | 2014-05-28 |
AP2013007143A0 (en) | 2013-09-30 |
AP3624A (fr) | 2016-03-02 |
WO2012123924A2 (fr) | 2012-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017030823A3 (fr) | Anticorps anti-tigit | |
PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
PH12015501648B1 (en) | 2-aminopyrimidine derivatives for the treatment of viral infections | |
EP3686200A3 (fr) | Composés hétérocycles bicycliques et leurs utilisations en thérapie | |
GB201209613D0 (en) | New compounds | |
WO2012103038A9 (fr) | Compositions de nanoparticules, leurs formulations et leurs utilisations | |
PH12015500724B1 (en) | 1, 2, 4-triazine derivatives for the treatment of viral infections | |
PH12015500713A1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
WO2014180889A8 (fr) | Méthodes et compositions destinées à traiter le cancer | |
PH12014502496B1 (en) | Bicyclically substituted uracils and the use thereof | |
NZ721952A (en) | Delayed release compositions of linaclotide | |
JO3122B1 (ar) | مشتقات إسترا-5،3،1(10)، 16- تترايين-3- كربوكساميد، عمليات لتحضيرها، مستحضرات دوائية تشتمل عليها واستخدامها لتحضير أدوية | |
MX2016005668A (es) | Formas cristalinas de compuestos terapeuticos y sus usos. | |
WO2015015378A3 (fr) | Inhibiteurs de rorc2 méthodes d'utilisation associées | |
WO2015058664A8 (fr) | Utilisation d'icariine pour préparer un médicament destiné à prévenir ou à traiter une baisse des cellules sanguines | |
WO2016011049A3 (fr) | Compositions et procédés pour le traitement de maladies à l'aide de composés distribués sous forme de nanoparticules | |
WO2015066302A3 (fr) | Compositions, méthodes d'utilisation et méthodes de traitement | |
WO2012040331A3 (fr) | Nanoparticules multicouches | |
WO2014064652A3 (fr) | Composition pharmaceutique stable d'interféron pégylé alpha-2b | |
WO2012123924A3 (fr) | Composition antimicrobienne | |
PH12015502564A1 (en) | Pyridone derivatives for the treatment of viral infections and further diseases | |
WO2013038195A3 (fr) | Compositions de nanoparticules pharmaceutiques | |
WO2013038200A3 (fr) | Troubles neurodéveloppementaux | |
WO2012158776A3 (fr) | Thérapie d'association pour le traitement du cancer | |
WO2015060702A8 (fr) | Composition pharmaceutique pour contrôler la prise de masse corporelle comprenant s-phénotropil |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12713353 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12713353 Country of ref document: EP Kind code of ref document: A2 |